相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。IL-1 and IL-1 regulatory pathways in cancer progression and therapy
Alberto Mantovani et al.
IMMUNOLOGICAL REVIEWS (2018)
The family of the interleukin-1 receptors
Diana Boraschi et al.
IMMUNOLOGICAL REVIEWS (2018)
Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke
David Yang-Wei Fann et al.
MOLECULAR NEUROBIOLOGY (2018)
Posttranscriptional regulation of lipid metabolism by non-coding RNAs and RNA binding proteins
Abhishek K. Singh et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Diverse exocytic pathways for mast cell mediators
Hao Xu et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2018)
NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma
Han Wang et al.
BMC CANCER (2018)
Targeting myeloid-derived suppressor cells for cancer immunotherapy
Yijun Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study
Jurgen Sota et al.
CLINICAL RHEUMATOLOGY (2018)
Multi-omic molecular profiling of lung cancer in COPD
Brian J. Sandri et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
A large lung gene expression study identifying IL1B as a novel player in airway inflammation in COPD airway epithelial cells
Gao Yi et al.
INFLAMMATION RESEARCH (2018)
Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma
Jorien Minnema-Luiting et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Gain of function mutation and inflammasome driven diseases in human and mouse models
Mario D. Cordero et al.
JOURNAL OF AUTOIMMUNITY (2018)
Biochemical and molecular study on interleukin-1 gene expression and relation of single nucleotide polymorphism in promoter region with Type 2 diabetes mellitus
Safaa I. Tayel et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial
Reinhard Dummer et al.
LANCET ONCOLOGY (2018)
Recent Advances in the Molecular Mechanisms Underlying Pyroptosis in Sepsis
Yu-Lei Gao et al.
MEDIATORS OF INFLAMMATION (2018)
Inflammasome biology, molecular pathology and therapeutic implications
Fawaz Awad et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Cancer Associated Fibroblasts: The Architects of Stroma Remodeling
Alice Santi et al.
PROTEOMICS (2018)
Prospective Analyses of Cytokine Mediation of Sleep and Survival in the Context of Advanced Cancer
Jennifer L. Steel et al.
PSYCHOSOMATIC MEDICINE (2018)
Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma
Naofumi Mukaida et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Cellular immunotherapy as a therapeutic approach in multiple myeloma
Jessica Liegel et al.
EXPERT REVIEW OF HEMATOLOGY (2018)
BRAF inhibitors stimulate inflammasome activation and interleukin 1 beta production in dendritic cells
Eva Hajek et al.
Oncotarget (2018)
Immunological Approaches Towards Cancer and Inflammation: A Cross Talk
Xinglong Qu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Role of inflammatory response in liver diseases: Therapeutic strategies
Jose A. Del Campo et al.
WORLD JOURNAL OF HEPATOLOGY (2018)
Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma
Lei Chen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
The diversity of circulating neutrophils in cancer
Inbal Mishalian et al.
IMMUNOBIOLOGY (2017)
Caspase-8: regulating life and death
Bart Tummers et al.
IMMUNOLOGICAL REVIEWS (2017)
Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression
Huifang Shi et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Post-Translational Modifications of the TAK1-TAB Complex
Yusuke Hirata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition
Helen L. Young et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
Benjamin Weichand et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Global Characterization of Protein Secretion from Human Macrophages Following Non-canonical Caspase-4/5 Inflammasome Activation
Martina B. Lorey et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
Activation of NLRP3 inflammasome in peripheral nerve contributes to paclitaxel-induced neuropathic pain
Min Jia et al.
MOLECULAR PAIN (2017)
Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling
Sam Strickson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System
Deepti Pilli et al.
FRONTIERS IN IMMUNOLOGY (2017)
Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation
Fawaz Awad et al.
PLOS ONE (2017)
Cytokines of the IL-1 family: recognized targets in chronic inflammation underrated in organ transplantations
Ilja Striz
CLINICAL SCIENCE (2017)
Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts
Manmeet K. Mamik et al.
BRAIN (2017)
MKP-1 negatively regulates LPS-mediated IL-1β production through p38 activation and HIF-1α expression
Harvinder Talwar et al.
CELLULAR SIGNALLING (2017)
SMC1A recruits tumor-associated-fibroblasts (TAFs) and promotes colorectal cancer metastasis
Pengyang Zhou et al.
CANCER LETTERS (2017)
Neutrophil proteolytic activation cascades: a possible mechanistic link between chronic periodontitis and coronary heart disease
Hatem Alfakry et al.
INNATE IMMUNITY (2016)
Epithelial IL-1R2 acts as a homeostatic regulator during remission of ulcerative colitis
R. Mora-Buch et al.
MUCOSAL IMMUNOLOGY (2016)
Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
Ole Audun Werner Haabeth et al.
ONCOIMMUNOLOGY (2016)
Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma
John A. Lust et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Intracellular interleukin (IL)-1 family cytokine processing enzyme
Areum Kwak et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
MDSCs in cancer: Conceiving new prognostic and therapeutic targets
Francesco De Sanctis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy
Michal Baniyash
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Tumor-associated macrophages and anti-tumor therapies: complex links
Cristina Belgiovine et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
The emerging role of miR-223 as novel potential diagnostic and therapeutic target for inflammatory disorders
Faisal Aziz
CELLULAR IMMUNOLOGY (2016)
Association of IL1I' (-511 A/C) and IL6 (-174 G > C) polymorphisms with higher disease activity and clinical pattern of psoriatic arthritis
N. Cubino et al.
CLINICAL RHEUMATOLOGY (2016)
E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets
Yulin Huang et al.
CURRENT CANCER DRUG TARGETS (2016)
Human Monocytes Engage an Alternative Inflammasome Pathway
Moritz M. Gaidt et al.
IMMUNITY (2016)
New roles for CD14 and IL-β linking inflammatory dendritic cells to IL-17 production in memory CD4+ T cells
Juan M. Ilarregui et al.
IMMUNOLOGY AND CELL BIOLOGY (2016)
Helicobacter pylori Infection Synergistic with IL-1β Gene Polymorphisms Potentially Contributes to the Carcinogenesis of Gastric Cancer
Jun-Bo Hong et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2016)
Lipopolysaccharide and IL-1β coordinate a synergy on cytokine production by upregulating MyD88 expression in human gingival fibroblasts
Colleen W. Brinson et al.
MOLECULAR IMMUNOLOGY (2016)
NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
Yuan He et al.
NATURE (2016)
NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations
Leanne Mortimer et al.
NATURE IMMUNOLOGY (2016)
The NLRP3 inflammasome in kidney disease and autoimmunity
Holly L. Hutton et al.
NEPHROLOGY (2016)
Pyrexia in dabrafenib-treated melanoma patients is not associated with common genetic variation or HLA polymorphisms
Diptee Kulkarni et al.
PHARMACOGENOMICS (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Interleukin-1 increases the risk of gastric cancer through induction of aberrant DNA methylation in a mouse model
Fung-Yu Huang et al.
ONCOLOGY LETTERS (2016)
Targeting the CCL2-CCR2 signaling axis in cancer metastasis
Su Yin Lim et al.
ONCOTARGET (2016)
Regulatory T Cells: Differentiation and Function
George Plitas et al.
CANCER IMMUNOLOGY RESEARCH (2016)
CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma
Guang-Tao Yu et al.
ONCOIMMUNOLOGY (2016)
LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma
Wei-Wei Deng et al.
ONCOIMMUNOLOGY (2016)
GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response
Paola De Marco et al.
SCIENTIFIC REPORTS (2016)
Targeting inflammasome/IL-1 pathways for cancer immunotherapy
Beichu Guo et al.
SCIENTIFIC REPORTS (2016)
The N-terminal loop of IRAK-4 death domain regulates ordered assembly of the Myddosome signalling scaffold
Anthony C. G. Dossang et al.
SCIENTIFIC REPORTS (2016)
Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways
Kannan Badri Narayanan et al.
APOPTOSIS (2015)
Compromised MAPK signaling in human diseases: an update
Eun Kyung Kim et al.
ARCHIVES OF TOXICOLOGY (2015)
Interleukin-1 as a therapeutic target in gout
Alexandre Dumusc et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
The interleukin (IL)-1 cytokine family - Balance between agonists and antagonists in inflammatory diseases
Jennifer Palomo et al.
CYTOKINE (2015)
Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme
Inna S. Afonina et al.
IMMUNITY (2015)
Myeloid regulatory cells in tumor spreading and metastasis
Anton A. Keskinov et al.
IMMUNOBIOLOGY (2015)
Regulation of inflammasome activation
Si Ming Man et al.
IMMUNOLOGICAL REVIEWS (2015)
Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling
Christina Antonopoulos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A RIPK3-Caspase 8 Complex Mediates Atypical Pro-IL-1β Processing
Kenta Moriwaki et al.
JOURNAL OF IMMUNOLOGY (2015)
Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages
Milena Sokolowska et al.
JOURNAL OF IMMUNOLOGY (2015)
IL-1 Receptor Type 2 Suppresses Collagen-Induced Arthritis by Inhibiting IL-1 Signal on Macrophages
Kenji Shimizu et al.
JOURNAL OF IMMUNOLOGY (2015)
NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced rat model
Chen-Chen Tan et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis
Tali Voloshin et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts
Yali Han et al.
TUMOR BIOLOGY (2015)
Interleukin-1 and acute brain injury
Katie N. Murray et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients
Huanhuan Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Cyclooxygenase-2 Regulates NLRP3 Inflammasome-Derived IL-1β Production
Kuo-Feng Hua et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
NLRP3 Mediates NF-kappa B Activation and Cytokine Induction in Microbially Induced and Sterile Inflammation
Takeshi Kinoshita et al.
PLOS ONE (2015)
Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma
Catherine Westbom et al.
PLOS ONE (2015)
A pan caspase inhibitor decreases caspase-1, IL-1α and IL-1β, and protects against necrosis of cisplatin-treated freshly isolated proximal tubules
Dong Won Lee et al.
RENAL FAILURE (2015)
IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3
Reiner K. W. Mailer et al.
SCIENTIFIC REPORTS (2015)
Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases
Christin Pilzweger et al.
DIAGNOSTICS (2015)
A Functional Synonymous Coding Variant in the IL1RN Gene Is Associated with Survival in Septic Shock
Nuala J. Meyer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Myeloid-derived suppressor cell heterogeneity in human cancers
Samantha Solito et al.
YEAR IN IMMUNOLOGY: MYELOID CELLS AND INFLAMMATION (2014)
Genetic Polymorphism of Interleukin-1A (IL-1A), IL-1B, and IL-1 Receptor Antagonist (IL-1RN) and Prostate Cancer Risk
Hua Xu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
The role of IL-1β and TNF-α signaling in the genesis of cancer treatment related symptoms (CTRS): A study using cytokine receptor-deficient mice
Logan B. Smith et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs Synergistic effects of doxorubicin and vincristine
John Wong et al.
CANCER BIOLOGY & THERAPY (2014)
Quantitative analysis of elastase and cathepsin G mRNA levels in peripheral blood CD14+ cells from patients with rheumatoid arthritis
Dorota Trzybulska et al.
CELLULAR IMMUNOLOGY (2014)
Regulatory T cells in cancer immunotherapy
Hiroyoshi Nishikawa et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Resident Macrophages Mediate Islet Amyloid PolypeptideInduced Islet IL-1b Production and b-Cell Dysfunction
Clara Y. Westwell-Roper et al.
DIABETES (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Interleukin-1β triggers the differentiation of macrophages with enhanced capacity to present mycobacterial antigen to T cells
Mirjam Schenk et al.
IMMUNOLOGY (2014)
Interleukin-1 blockade in rheumatoid arthritis and heart failure: A missed opportunity?
Antonio Abbate et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
An inherited mutation in NLRC4 causes autoinflammation in human and mice
Akiko Kitamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Excess IL-1 Signaling Enhances the Development of Th17 Cells by Downregulating TGF-β-Induced Foxp3 Expression
Satoshi Ikeda et al.
JOURNAL OF IMMUNOLOGY (2014)
Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis
Lieselotte Vande Walle et al.
NATURE (2014)
The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response
Alberto Baroja-Mazo et al.
NATURE IMMUNOLOGY (2014)
P2X7 receptor blockade protects against cisplatin-induced nephrotoxicity in mice by decreasing the activities of inflammasome components, oxidative stress and caspase-3
Yuanyuan Zhang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Allele-Specific Induction of IL-1β Expression by C/EBPβ and PU.1 Contributes to Increased Tuberculosis Susceptibility
Guoliang Zhang et al.
PLOS PATHOGENS (2014)
The roles of Pellino E3 ubiquitin ligases in immunity
Paul N. Moynagh
NATURE REVIEWS IMMUNOLOGY (2014)
Cancer Associated Fibroblasts express pro-inflammatory factors in human breast and ovarian tumors
Neta Erez et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
IL-1 receptor 2 (IL-1R2) and its role in immune regulation
Vanessa A. Peters et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
How biologics targeting the IL-1 system are being considered for the treatment of type 2 diabetes
Marianne Boeni-Schnetzler et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population
M. Dwivedi et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
The pre-metastatic niche: finding common ground
Jaclyn Sceneay et al.
CANCER AND METASTASIS REVIEWS (2013)
Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of Doxorubicin
John Wong et al.
CANCER BIOLOGY & THERAPY (2013)
Interleukin-1β induced by Helicobacter pylori infection enhances mouse gastric carcinogenesis
Yasuyuki Shigematsu et al.
CANCER LETTERS (2013)
Characterization of interleukin-1β in Helicobacter pylori-induced gastric inflammation and DNA methylation in interleukin-1 receptor type 1 knockout (IL-1R1-/-) mice
Fung-Yu Huang et al.
EUROPEAN JOURNAL OF CANCER (2013)
The Interleukin-1 Family: Back to the Future
Cecilia Garlanda et al.
IMMUNITY (2013)
Tumor associated macrophages and neutrophils in cancer
Maria Rosaria Galdiero et al.
IMMUNOBIOLOGY (2013)
The Role of IL-1β in the Early Tumor Cell-Induced Angiogenic Response
Yaron Carmi et al.
JOURNAL OF IMMUNOLOGY (2013)
Proapoptotic Chemotherapeutic Drugs Induce Noncanonical Processing and Release of IL-1β via Caspase-8 in Dendritic Cells
Christina Antonopoulos et al.
JOURNAL OF IMMUNOLOGY (2013)
Two Phases of Inflammatory Mediator Production Defined by the Study of IRAK2 and IRAK1 Knock-in Mice
Eduardo Pauls et al.
JOURNAL OF IMMUNOLOGY (2013)
Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions
Praxedis Martin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
How glucocorticoid receptors modulate the activity of other transcription factors: A scope beyond tethering
Dariusz Ratman et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
The NLRP3 Inflammasome in Alzheimer's Disease
Meng-Shan Tan et al.
MOLECULAR NEUROBIOLOGY (2013)
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
Melanie Bruchard et al.
NATURE MEDICINE (2013)
NF-κB-Dependent Role for Cold-Inducible RNA Binding Protein in Regulating Interleukin 1β
Christian Brochu et al.
PLOS ONE (2013)
Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4
Nobuhiko Kayagaki et al.
SCIENCE (2013)
Treating inflammation by blocking interleukin-1 in humans
Charles A. Dinarello et al.
SEMINARS IN IMMUNOLOGY (2013)
Tumor-associated macrophages: functional diversity, clinical significance, and open questions
Subhra K. Biswas et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
Interleukin-1β Promotes Ovarian Tumorigenesis through a p53/NF-κB-Mediated Inflammatory Response in Stromal Fibroblasts
Isaiah Gregory Schauer et al.
NEOPLASIA (2013)
IL-1β Strikingly Enhances Antigen-Driven CD4 and CD8 T-Cell Responses
S. Z. Ben-Sasson et al.
IMMUNITY AND TOLERANCE (2013)
Tumor-Infiltrating Regulatory T Cells: Phenotype, Role, Mechanism of Expansion In Situ and Clinical Significance
C. Tanchot et al.
CANCER MICROENVIRONMENT (2013)
Chemotherapeutic Targeting of Cell Death Pathways
Sylvia Mansilla et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in han chinese
Jiangdong Sui et al.
ARTHRITIS AND RHEUMATISM (2012)
Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
Paola Filipazzi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Helical assembly in the death domain (DD) superfamily
Ryan Ferrao et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2012)
The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II
Inken Lorenzen et al.
FEBS LETTERS (2012)
Kruppel-like factor 4 inhibits the expression of interleukin-1 beta in lipopolysaccharide-induced RAW264.7 macrophages
Junwen Liu et al.
FEBS LETTERS (2012)
Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation
Christine Juliana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cutting Edge: Nitric Oxide Inhibits the NLRP3 Inflammasome
Eduardo Hernandez-Cuellar et al.
JOURNAL OF IMMUNOLOGY (2012)
Cutting Edge: FAS (CD95) Mediates Noncanonical IL-1β and IL-18 Maturation via Caspase-8 in an RIP3-Independent Manner
Lukas Bossaller et al.
JOURNAL OF IMMUNOLOGY (2012)
Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1β Production
Moritz Haneklaus et al.
JOURNAL OF IMMUNOLOGY (2012)
Molecular characterization of a cancer-related single nucleotide polymorphism in the pro-inflammatory interleukin-1B gene
N. E. Landvik et al.
MOLECULAR CARCINOGENESIS (2012)
Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
Joannes F. M. Jacobs et al.
LANCET ONCOLOGY (2012)
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Christina E. Zielinski et al.
NATURE (2012)
Inflammasomes in carcinogenesis and anticancer immune responses
Laurence Zitvogel et al.
NATURE IMMUNOLOGY (2012)
IL1 Receptor Antagonist Gene IL1-RN Variable Number of Tandem Repeats Polymorphism and Cancer Risk: A Literature Review and Meta-Analysis
Ying Zhang et al.
PLOS ONE (2012)
New insights into chronic inflammation-induced immunosuppression
Julia Kanterman et al.
SEMINARS IN CANCER BIOLOGY (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Leptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling
W. Zhou et al.
BRITISH JOURNAL OF CANCER (2011)
Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome
Kristin A. D. Sauter et al.
CANCER BIOLOGY & THERAPY (2011)
The Unholy Trinity: Inflammation, Cytokines, and STAT3 Shape The Cancer Microenvironment
Ning Li et al.
CANCER CELL (2011)
Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
Stephen R. Mattarollo et al.
CANCER RESEARCH (2011)
Cyst Fluid Interleukin-1β (IL1β) Levels Predict the Risk of Carcinoma in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Ajay V. Maker et al.
CLINICAL CANCER RESEARCH (2011)
New plays in the p53 theater
Yael Aylon et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Facultative heterochromatin formation at the IL-1 beta promoter in LPS tolerance and sepsis
Barbara K. Yoza et al.
CYTOKINE (2011)
Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
Christiane Meyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Thomas Condamine et al.
TRENDS IN IMMUNOLOGY (2011)
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
Ole Audun Werner Haabeth et al.
NATURE COMMUNICATIONS (2011)
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
Suzanne Ostrand-Rosenberg
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Immature Immunosuppressive CD14+HLA-DR-/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
Isabel Poschke et al.
CANCER RESEARCH (2010)
Myeloid-derived suppressor cell heterogeneity and subset definition
Elisa Peranzoni et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Changes in chromatin structure and methylation of the human interleukin-1β gene during monopoiesis
Inga Wessels et al.
IMMUNOLOGY (2010)
The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
Irving C. Allen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The RNA binding protein tristetraprolin influences the activation state of murine dendritic cells
Matthias Bros et al.
MOLECULAR IMMUNOLOGY (2010)
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 beta in type 2 diabetes
Seth L. Masters et al.
NATURE IMMUNOLOGY (2010)
Cathepsin G is differentially expressed in primary human antigen-presenting cells
Christina Stoeckle et al.
CELLULAR IMMUNOLOGY (2009)
Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment
M. SHERMAN
CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)
Interleukin 1 regulates its own receptors in human endometrial cells via distinct mechanisms
C. Bellehumeur et al.
HUMAN REPRODUCTION (2009)
Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
Caroline E. Sutton et al.
IMMUNITY (2009)
An Oligomeric Signaling Platform Formed by the Toll-like Receptor Signal Transducers MyD88 and IRAK-4
Precious G. Motshwene et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Differential Role for c-Rel and C/EBPβ/δ in TLR-Mediated Induction of Proinflammatory Cytokines
Yong-Chen Lu et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Alternate Splicing of Interleukin-1 Receptor Type II (IL1R2) In Vitro Correlates with Clinical Glucocorticoid Responsiveness in Patients with AIED
Andrea Vambutas et al.
PLOS ONE (2009)
Identification of the phosphorylation sites on the E3 ubiquitin ligase Pellino that are critical for activation by IRAK1 and IRAK4
Hilary Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome
Shankar S. Iyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors-Insight into Heterotrimeric IL-1 Signaling Complexes
Andreas Lingel et al.
STRUCTURE (2009)
The metastatic niche: adapting the foreign soil
Bethan Psaila et al.
NATURE REVIEWS CANCER (2009)
Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis
Johanna R. Reed et al.
BREAST CANCER RESEARCH (2009)
The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys(63)-linked polyubiquitination of IRAK1
Alban Ordureau et al.
BIOCHEMICAL JOURNAL (2008)
Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice
Shuiping Tu et al.
CANCER CELL (2008)
Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?
Ron N. Apte et al.
IMMUNOLOGICAL REVIEWS (2008)
The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress
Luke A. J. O'Neill
IMMUNOLOGICAL REVIEWS (2008)
TRAF6 Autoubiquitination-Independent Activation of the NFκB and MAPK Pathways in Response to IL-1 and RANKL
Matthew C. Walsh et al.
PLOS ONE (2008)
Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1
Fumihiko Mouri et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells
Eva V. Acosta-Rodriguez et al.
NATURE IMMUNOLOGY (2007)
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats
Annemarie Ledeboer et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells
Pratima Sinha et al.
CANCER RESEARCH (2007)
Stimulation of P2 receptors causes release of IL-1β-loaded microvesicles from human dendritic cells
Cinzia Pizzirani et al.
BLOOD (2007)
Regulated intramembrane proteolysis of the interleukin-1 receptor II by α-, β-, and γ-secretase
Peer-Hendrik Kuhn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Interleukin-1β-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors
Yakov Krelin et al.
CANCER RESEARCH (2007)
A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis
Caroline Sutton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1β (IL-1β) in astrocyte cultures
Wandong Zhang et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
The interleukin-1β gene is transcribed from a poised promoter architecture in monocytes
MD Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions
RN Apte et al.
EUROPEAN JOURNAL OF CANCER (2006)
Transcription factor YY1: structure, function, and therapeutic implications in cancer biology
S Gordon et al.
ONCOGENE (2006)
Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context
HM Chen et al.
HUMAN MOLECULAR GENETICS (2006)
Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression
SK Bunt et al.
JOURNAL OF IMMUNOLOGY (2006)
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
Ron N. Apte et al.
CANCER AND METASTASIS REVIEWS (2006)
MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus
LS Miller et al.
IMMUNITY (2006)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
JH Shim et al.
GENES & DEVELOPMENT (2005)
Essential function for the kinase TAK1 in innate and adaptive immune responses
S Sato et al.
NATURE IMMUNOLOGY (2005)
Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1β-induced neovascularization and tumor growth
S Nakao et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling
C Kollewe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Hypoxic gene activation by lipopolysaccharide in macrophages:: Implication of hypoxia-inducible factor 1α
CC Blouin et al.
BLOOD (2004)
Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding
XL Cui et al.
JOURNAL OF IMMUNOLOGY (2003)
Mechanisms of caspase activation
KM Boatright et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
IL-1 is required for tumor invasiveness and angiogenesis
E Voronov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Local delivery of IL-1 alpha polymeric microspheres for the immunotherapy of an experimental fibrosarcoma
J Mullerad et al.
CANCER INVESTIGATION (2003)
Negative regulation of cytokine signaling influences inflammation
A Yoshimura et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2002)
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
K Maedler et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Extracellular ATP and P2X7 receptors in neurodegeneration
R Le Feuvre et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Proinflammatory cytokine IL-1β promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors:: In vivo analysis of tumor-stromal interaction
Y Saijo et al.
JOURNAL OF IMMUNOLOGY (2002)
IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase
SY Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Autocrine induction of the human pro-IL-1β gene promoter by IL-1β in monocytes
Y Toda et al.
JOURNAL OF IMMUNOLOGY (2002)
Rapid secretion of interleukin-1β by microvesicle shedding
A MacKenzie et al.
IMMUNITY (2001)
PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1β gene
S Marecki et al.
JOURNAL OF IMMUNOLOGY (2001)
The microenvironment of the tumour-host interface
LA Liotta et al.
NATURE (2001)
The first two N-terminal immunoglobulin-like domains of soluble human IL-1 receptor type II are sufficient to bind and neutralize IL-1β
C Kollewe et al.
FEBS LETTERS (2000)
Transcriptional regulation of the human interleukin 1β gene by fibronectin:: Role of protein kinase C and activator protein 1 (AP-1)
J Roman et al.
CYTOKINE (2000)
Macrophage activation for the production of immunostimulatory cytokines by delivering interleukin 1 via biodegradable microspheres
J Mullerad et al.
CYTOKINE (2000)
Biological role of interleukin 1 receptor antagonist isoforms
WP Arend et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
The membrane form of the type IIIL-1 receptor accounts for inhibitory function
D Neumann et al.
JOURNAL OF IMMUNOLOGY (2000)
NF-IL6 (C/EBPβ) vigorously activates il1b gene expression via a Spi-1 (PU.1) protein-protein tether
ZY Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor
K Burns et al.
NATURE CELL BIOLOGY (2000)
IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein
LE Jensen et al.
JOURNAL OF IMMUNOLOGY (2000)
Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme
P Reddy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
EM El-Omar et al.
NATURE (2000)
IL-18 regulates IL-1β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1
F Vidal-Vanaclocha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)